De-Escalation of Dual Antiplatelet Therapy: Will We Ever Get to the Right Method?

J Cardiovasc Pharmacol. 2022 Aug 1;80(2):203-205. doi: 10.1097/FJC.0000000000001304.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Dual Anti-Platelet Therapy
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / adverse effects
  • Prasugrel Hydrochloride / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride